« Previous
Next »
Psychiatry Research
Volume 169, Issue 2
, Pages 113-117
, 30 September 2009
Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder
References
- . Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing. Psychopharmacology Bulletin. 1996;32:27–32
- . Depression and public health: an overview. Journal of Psychosomatic Research. 2002;53:849–857
- . A molecular and cellular theory of depression. Archives of General Psychiatry. 1997;54:597–606
- . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical and Biophysical Research Communications. 1989;161:851–858
- . Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology. 1967;6:278–296
- . Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2007;31:658–663
- . VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nature Genetics. 2003;34:383–394
- . Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. The Journal of Neuroscience. 2003;23:10841–10851
- . Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biological Psychiatry. 1994;36:467–471
- . Differentiation of two genetically specific types of depression by the response to antidepressant drugs. Journal of Medical Genetics. 1971;8:306–309
- . Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biological Psychiatry. 2002;51:723–732
- . Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molecular Psychiatry. 1998;3:508–511
- . VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays. 2004;26:943–954
- . VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. The Journal of Clinical Investigation. 2003;111:1843–1851
- . The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. The Journal of Biological Chemistry. 1991;266:11947–11954
- . Pharmacogenetics of selective serotonin reuptake inhibitor response in major depression. Current Pharmacogenomics. 2003;1:1–7
- . VEGF expression is developmentally regulated during human brain angiogenesis. Histochemistry and Cell Biology. 2003;119:227–232
- . VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:4647–4652
- . VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case–control and TDT studies. European Journal of Human Genetics. 2007;15:1246–1251
- . Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Molecular Psychiatry. 2002;7:1115–1119
PII: S0165-1781(08)00195-9
doi: 10.1016/j.psychres.2008.06.028
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Psychiatry Research
Volume 169, Issue 2
, Pages 113-117
, 30 September 2009
